SPONSOR
Tianjin Medical University
Total Trials
4
Recruiting
4
Phases
EARLY_Phase 1
Conditions studied: Neurodegenerative DiseaseAlzheimer s DiseaseTauopathiesAmyloidCardiac AmyloidosisAmyloidosisCytomegalovirus RetinitisGanciclovir Eye DropsCXCR4-related DiseaseTumor
Tianjin Medical University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Neurodegenerative Disease, Alzheimer s Disease, Tauopathies, Amyloid.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tianjin Medical University
How many clinical trials has Tianjin Medical University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Tianjin Medical University, of which 4 are actively recruiting participants. These trials cover conditions including Neurodegenerative Disease, Alzheimer s Disease, Tauopathies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tianjin Medical University research focus on?
Tianjin Medical University clinical trials span Neurodegenerative Disease, Alzheimer s Disease, Tauopathies, Amyloid, Cardiac Amyloidosis, and additional conditions. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tianjin Medical University clinical trial?
To participate in a Tianjin Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tianjin Medical University trials with current recruitment status updated daily.
Clinical Trials by Tianjin Medical University
NCT07306598
Recruiting
[18F]NIDF PET Imaging in Tau-related Diseases
Neurodegenerative Disease
NCT07130565
Recruiting
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
Amyloid
NCT05911503 EARLY_Phase 1
Recruiting
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
Cytomegalovirus Retinitis
NCT06690736
Recruiting
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
CXCR4-related Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology